Indiscriminate SARS-CoV-2 multivariant detection using magnetic nanoparticle-based electrochemical immunosensing
Ceren Durmus(Ege University), Suna Tımur(Ege University), Figen Zihnioğlu(Ege University), Kutsal Turhan(Ege University), Serap Evran(Ege University), Rüçhan Sertöz(Ege University), Bilgin Arda(Ege University), Faezeh Ghorbanizamani(Ege University), Tuncay Göksel(Heidelberg University), Duygu Harmancı(Ege University), Simge Balaban Hanoglu(Ege University), Kerem Tok(Ege University), Hichem Moulahoum(Ege University), Candan Çiçek(Ege University), Serdar Şanlı(Ege University)
Cited by 42
Related Papers
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2008|3.2k
The LOD paradox: When lower isn't always better in biosensor research and development
|Biosensors and Bioelectronics|2024|95
Surface Biomodification of Liposomes and Polymersomes for Efficient Targeted Drug Delivery
|Bioconjugate Chemistry|2021|67
Application of Biofunctionalized Magnetic Nanoparticles Based-Sensing in Abused Drugs Diagnostics
|Analytical Chemistry|2019|54
Ionic Liquids from Biocompatibility and Electrochemical Aspects toward Applying in Biosensing Devices
|Analytical Chemistry|2017|48